DK1150702T3 - Anvendelse af orosomucoid til fremstilling af et farmaceutisk præparat til behandling af pancreatitis - Google Patents

Anvendelse af orosomucoid til fremstilling af et farmaceutisk præparat til behandling af pancreatitis

Info

Publication number
DK1150702T3
DK1150702T3 DK00903429T DK00903429T DK1150702T3 DK 1150702 T3 DK1150702 T3 DK 1150702T3 DK 00903429 T DK00903429 T DK 00903429T DK 00903429 T DK00903429 T DK 00903429T DK 1150702 T3 DK1150702 T3 DK 1150702T3
Authority
DK
Denmark
Prior art keywords
orosomucoid
treatment
pancreatitis
preparation
pharmaceutical composition
Prior art date
Application number
DK00903429T
Other languages
English (en)
Inventor
Wilfried Auer
Eva-Maria Muchitsch
Ludwig Pichler
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK1150702T3 publication Critical patent/DK1150702T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00903429T 1999-02-18 2000-02-15 Anvendelse af orosomucoid til fremstilling af et farmaceutisk præparat til behandling af pancreatitis DK1150702T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0027199A AT408946B (de) 1999-02-18 1999-02-18 Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation
PCT/AT2000/000038 WO2000048624A2 (de) 1999-02-18 2000-02-15 Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation

Publications (1)

Publication Number Publication Date
DK1150702T3 true DK1150702T3 (da) 2003-02-24

Family

ID=3486111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00903429T DK1150702T3 (da) 1999-02-18 2000-02-15 Anvendelse af orosomucoid til fremstilling af et farmaceutisk præparat til behandling af pancreatitis

Country Status (10)

Country Link
EP (1) EP1150702B1 (da)
JP (1) JP2002538087A (da)
AT (2) AT408946B (da)
AU (1) AU2525700A (da)
CA (1) CA2362664A1 (da)
DE (1) DE50000676D1 (da)
DK (1) DK1150702T3 (da)
ES (1) ES2187440T3 (da)
PT (1) PT1150702E (da)
WO (1) WO2000048624A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904289D0 (sv) 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6118723A (ja) * 1984-07-05 1986-01-27 Chemo Sero Therapeut Res Inst 肝疾患治療剤
CA2171832C (en) * 1993-09-15 2001-01-02 Harutyun Eran Alpha1-acid glycoprotein purification process and product
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
AT405241B (de) * 1997-03-10 1999-06-25 Immuno Ag Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation

Also Published As

Publication number Publication date
ATE226443T1 (de) 2002-11-15
CA2362664A1 (en) 2000-08-24
ATA27199A (de) 2001-09-15
JP2002538087A (ja) 2002-11-12
ES2187440T3 (es) 2003-06-16
DE50000676D1 (de) 2002-11-28
AT408946B (de) 2002-04-25
EP1150702B1 (de) 2002-10-23
EP1150702A2 (de) 2001-11-07
AU2525700A (en) 2000-09-04
WO2000048624A3 (de) 2000-12-14
WO2000048624A2 (de) 2000-08-24
PT1150702E (pt) 2003-03-31

Similar Documents

Publication Publication Date Title
NO2012018I2 (no) Canakinumab eller direkte ekvivalenter derav
DK1524266T3 (da) Farmaceutisk sammensætning
DK2412368T3 (da) Sammensætning til behandling af ar
NO20025450L (no) Ny farmasöytisk sammensetning
IS6686A (is) Hýdrógel-drifið lyfjaskömmtunarform
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
EE200300145A (et) Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon
DE60143252D1 (de) Dentalklebstoffzusammensetzung
NO20015175D0 (no) Farmasöytisk sammensetning
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
FR2810237B1 (fr) Composition cosmetique filmogene
DK1156806T3 (da) Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
FR2815851B1 (fr) Composition cosmetique filmogene
EE05020B1 (et) Glburiidi ravimkoostis
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DK1309545T3 (da) Fremgangsmåde til fremstilling af alkylarylsulfonater
FR2810238B1 (fr) Composition cosmetique filmogene
FR2814673B1 (fr) Composition cosmetique filmogene
FR2810236B1 (fr) Composition cosmetique filmogene
FR2810239B1 (fr) Composition cosmetique filmogene
ITMI20011637A0 (it) Composizione farmaceutica contenente citalopram
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
DE60008839D1 (de) Duftstoff-Zusammensetzung
FI4488U1 (fi) Farmaseuttinen koostumus